York Pei, University of Toronto

Research

Clinical Research Genetic Epidemiology Healthcare Cost Analysis Population Health Genotype-Phenotype Correlation Kidney Volume Imaging Polycystic Kidney Disease

Latest papers

Renal Cyst Sclerotherapy in Autosomal Dominant Polycystic Kidney Disease: Long-Term Follow-Up and Evaluation in a Porcine Bladder Model.
Kidney360 · 2026
Improving Early Risk Prediction for Autosomal Dominant Polycystic Kidney Disease.
Journal of the American Society of Nephrology : JASN · 2026 · senior author
Autosomal dominant polycystic kidney disease.
Lancet (London, England) · 2026 · senior author

All 90 publications

Latest funding

The role of myocardin-related transcription factor (MRTF) in polycystic kidney disease
CIHR · 2021 · Co-investigator
$833,850
Refining risk prediction for progression of autosomal dominant polycystic kidney disease
CIHR · 2021 · Nominated PI
$768,824
Disease-Related Complications and Health Care Utilization in ADPKD
CIHR · 2016 · Nominated PI
$832,320

All 6 grants and awards

90 publications.

01

Renal Cyst Sclerotherapy in Autosomal Dominant Polycystic Kidney Disease: Long-Term Follow-Up and Evaluation in a Porcine Bladder Model.

Copping RRW, Sabovich S, Li P, Miranda Cam M, Dehkharghanian T, Pei Y, Swanstrom L, Shlomovitz E

Kidney3602026

DOI: 10.34067/kid.0000001259 PMID: 42530878

02

Improving Early Risk Prediction for Autosomal Dominant Polycystic Kidney Disease.

Carriazo S, Pei Y

Journal of the American Society of Nephrology : JASN2026Senior author

DOI: 10.1681/asn.0000001074 PMID: 41915441

03

Autosomal dominant polycystic kidney disease.

Ong ACM, Carriazo S, Ma BM, Torra R, Pei Y

Lancet (London, England)2026Senior author

DOI: 10.1016/s0140-6736(26)00046-2 PMID: 41771281

04

Association of Kidney Volume With Patient-Reported Outcomes in ADPKD

Fadlallah J, Ho M, Hassan MT, Dehkharghanian T, Cam MM, Lee SH, Khowaja S, Bichet DG, Brown PA, Lanktree MB

Kidney International Reports20263 citationsSenior author

DOI: 10.1016/j.ekir.2026.103787

05

Response to “Beyond Pain: Sarcopenia, Malnutrition, and Sex-Specific Body Image Distortion as Potential Additional Mediators of HRQOL Impairment in ADPKD”

Fadlallah J, Ho M, Hassan MT, Dehkharghanian T, Cam MM, Lee SH, Khowaja S, Bichet DG, Brown PA, Lanktree MB

Kidney International Reports2026Senior author

DOI: 10.1016/j.ekir.2026.106680

06

Canadian Society of Nephrology Commentary on the 2025 Kidney Disease Improving Global Outcomes Clinical Practice Guidelines for Autosomal Dominant Polycystic Kidney Disease

Lanktree MB, Ashawasega N, Bevilacqua M, Bichet DG, Bollée G, Brown P-A, Girard L, Goodyer P, Hingwala J, Lemaire M

Canadian Journal of Kidney Health and Disease2026

DOI: 10.1177/20543581261455635

07

Response to the Letter to the Editor Entitled "Beneath the Surface: Rethinking Concordance in Renal Imaging and Function for ADPKD".

Lee SH, Pei Y

Kidney international reports2025Senior author

DOI: 10.1016/j.ekir.2025.08.003 PMID: 41141522

08

How to Enhance Kidney Donation around the World: A Summary of Expert Opinions from the 5th International Congress of Chinese Nephrologists.

Li PKT, Lau LFS, Chow KM, Choo JCJ, Hooi LS, Lee MC, Lim WH, Pei Y, Tam FW, Yeung MY, Tang SYH, Tian N, Chen J

Kidney diseases (Basel, Switzerland)2025

DOI: 10.1159/000548765 PMID: 41321789

09

Do Overweight Status and Obesity Affect Progression to ESKD in Autosomal Dominant Polycystic Kidney Disease?

Carriazo S, Pei Y

Clinical journal of the American Society of Nephrology : CJASN2025Senior author

DOI: 10.2215/cjn.0000000690 PMID: 40080071

10

Patients With Mild ADPKD by Kidney Imaging but Low Estimated GFR.

Lee SH, Cam MM, Dehkharghanian T, Nasri F, Khowaja S, Haghighi A, Song X, Khalili K, Pei Y

Kidney international reports2025Senior author

DOI: 10.1016/j.ekir.2025.03.045 PMID: 40630282

The role of myocardin-related transcription factor (MRTF) in polycystic kidney disease

Co-investigatorCIHR2021Project Grant

Principal investigators: Kapus, Andras

Keywords: Myocardin-Related Transcription Factor (Mrtf); Organ Fibrosis; Pathobiology; Polycystic Kidney Disease; Rho Signaling; Tubular Epithelium

$833,850

Refining risk prediction for progression of autosomal dominant polycystic kidney disease

Nominated PICIHR2021Project Grant

Principal investigators: Pei, York P

Keywords: Clinical Research

$768,824

Disease-Related Complications and Health Care Utilization in ADPKD

Nominated PICIHR2016Project Grant

Principal investigators: Pei, York P

Keywords: Genetic Epidemiology; Healthcare Cost Analysis

$832,320

Improving Autosomal Dominant Polycystic Kidney Disease Prognostication using Imaging, Next Generation Sequencing and Urinary Biomarkers

SupervisorCIHR2016CIHR Fellowship

Principal investigators: Lanktree, Matthew B

Keywords: Chronic Disease; Chronic Kidney Disease; Dialysis; Genetics; Magnetic Resonance Imaging; Next Generation Sequencing; Polycystic Kidney Disease; Prediction Models; Urine Biomarkers; Whole Genome Sequencing

$110,000

Disease-related complications and healthcare utilization in ADPKD

Nominated PICIHR2015Operating Grant

Principal investigators: Pei, York P

Keywords: Population Health

$100,000

Refining Genotype-Phenotype Correlation of ADPKD

Nominated PICIHR2012Operating Grant

Principal investigators: Pei, York P

Keywords: Genotype-Phenotype Correlation; Kidney Volume Imaging; Polycystic Kidney Disease

$283,302

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Medicine
Medicine/Nephrology
Health Research Methods, Evidence, and Impact
Department of Epidemiology and Biostatistics
Department of Surgery
Internal Medicine
Medical Imaging
Other

1 shared papers, latest 2019

Vladimir Belostotsky

Pediatrics

1 shared papers, latest 2020

Michael Walsh

Medicine

1 shared papers, latest 2018

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2021

Subject: Prospective PhD student: Clinical Research Dear Professor Pei, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Renal Cyst Sclerotherapy in Autosomal Dominant Polycystic Kidney Disease: Long-Term Follow-Up and Evaluation in a Porcine Bladder Model." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Refining risk prediction for progression of autosomal dominant polycystic kidney disease" (2021), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]